10-Q: Body and Mind Inc. Reports Mixed Results in Q2 2024, Strategic Divestments Underway

Body and Mind Inc. reports a net loss for Q2 2024, but shows improved gross margins and strategic divestments of assets.

Summary

• Body and Mind Inc. reported a net loss of $168,800 for the three months ended January 31, 2024, compared to a net loss of $2,741,048 for the same period in 2023.
• The company's gross profit increased to $2,022,396 from $1,770,810 year-over-year, driven by reduced cost of sales.
• Operating expenses decreased slightly to $2,866,475 from $3,204,237 year-over-year.
• The company's net loss from continuing operations was $1,464,919, while discontinued operations contributed a net income of $1,296,119, primarily due to the gain on the sale of NMG.
• For the six months ended January 31, 2024, the company's net loss was $4,985 compared to a net loss of $5,693,843 in 2023.
• The company's cash reserves were $1,455,250 as of January 31, 2024, with a working capital deficit of $5,961,758.
• The company is strategically divesting assets, including the sale of NMG OH 1 for $8.225 million and NMG for $2 million, to improve its financial position.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with some positive developments (improved gross margin, strategic divestments) offset by negative factors (net loss, working capital deficit, ineffective internal controls). The strategic shift is positive but the financial position is still weak.

Positives

• The company's gross margin improved due to reduced cost of sales.
• The company's net loss significantly decreased year-over-year.
• The company successfully divested NMG OH 1 and NMG, generating significant cash inflows.
• The company fully repaid its senior secured loan, reducing its debt burden.

Negatives

• The company reported a net loss from continuing operations of $1,464,919 for the three months ended January 31, 2024.
• The company has a working capital deficit of $5,961,758 as of January 31, 2024.
• The company's cash reserves decreased slightly to $1,455,250 as of January 31, 2024.

Risks

• The company has a significant working capital deficit, which may require additional financing.
• The company's ability to achieve profitability is dependent on the successful execution of its strategic divestment plan and improved operational performance.
• The company's financial results are subject to fluctuations in the cannabis market and regulatory changes.
• The company's internal controls over financial reporting were deemed not effective as of January 31, 2024.

Future Outlook

The company anticipates that current operations, cash on hand, and working capital will ensure coverage for all expenses associated with current operations for at least the next 12 months. Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities to further contribute to the growth of the company.

Industry Context

The company is operating in the competitive cannabis industry, which is subject to regulatory changes and market fluctuations. The company's strategic divestments and focus on limited license states are aligned with industry trends of consolidation and efficiency.

Comparison to Industry Standards

• The company's gross margin improvement indicates a positive trend compared to industry averages, which have been under pressure due to price compression.
• The company's strategic divestments are similar to actions taken by other cannabis companies to streamline operations and focus on core markets.
• The company's working capital deficit is a concern, as many cannabis companies are facing similar challenges in securing capital.
• The company's net loss, while improved, is still a common issue in the cannabis industry, where many companies are still in the growth phase and not yet profitable.
• The company's focus on limited license states is a common strategy to reduce competition and increase market share, similar to companies like Curaleaf and Green Thumb Industries.

Related Party Transactions

• The company had related party transactions with entities controlled by directors and officers, including management fees and convertible debenture financing.
• The company assigned a convertible loan agreement to a related entity, Big Stone Farms AR 1, LLC.

Stakeholder Impact

• Shareholders may be concerned about the company's net loss and working capital deficit.
• Employees may be affected by the company's strategic divestments.
• Customers may experience changes in the company's operations due to the divestments.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company will continue to execute its strategic divestment plan.
• The company will work to improve its internal controls over financial reporting.
• The company will seek additional financing to address its working capital deficit.

Key Dates

Keywords

cannabis, financial results, divestment, net loss, gross margin, operating expenses, working capital, loan repayment, strategic shift, discontinued operations